The effect of glutamine supplementation in children with respiratory infectio
Not Applicable
Recruiting
- Conditions
- Respiratory infection.Lung infections, unspecifiedCA4Z
- Registration Number
- IRCT20210913052455N1
- Lead Sponsor
- Ardabil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Age between 2 to 6 years
Having a respiratory infection
Willingness to cooperate
Exclusion Criteria
Unwilling to cooperate
Existence of chronic disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Interleukin 1 beta (IL-1B). Timepoint: At the baseline of the study and after 5 days intervention. Method of measurement: Standard kit.;Tumor necrosis factor-alpha. Timepoint: At the baseline of the study and after 5 days intervention. Method of measurement: standard kit.;Malondialdehyde. Timepoint: At the baseline of the study and after 5 days intervention. Method of measurement: standard kit.;Total antioxidant capacity. Timepoint: At the baseline of the study and after 5 days intervention. Method of measurement: standard kit.;Appetite. Timepoint: At the baseline of the study and after 5 days intervention. Method of measurement: The Appetite and Diet Assessment Tool.
- Secondary Outcome Measures
Name Time Method